Catalent
CTLT
#1495
Rank
โ‚น983.23 B
Marketcap
โ‚น5,417
Share price
0.00%
Change (1 day)
16.50%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -โ‚น105.61

According to Catalent's latest financial reports the company's current EPS (TTM) is -โ‚น110.08. In 2022 the company made an earnings per share (EPS) of โ‚น193.71 a decrease over its 2021 EPS that were of โ‚น279.04.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น105.61-154.52%
2022โ‚น193.71-30.58%
2021โ‚น279.0479.67%
2020โ‚น155.31114.12%
2019โ‚น72.53-15%
2018โ‚น85.3375.44%
2017โ‚น48.64-22.97%
2016โ‚น63.15-59.56%
2015โ‚น156.16282.05%
2014โ‚น40.87-378.2%
2013-โ‚น14.69

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น67.41-161.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น64.00-41.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น120.32 9.30%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚น545.28-595.35%๐Ÿ‡บ๐Ÿ‡ธ USA